Analysts Set Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Target Price at $26.85

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have been assigned a consensus rating of “Hold” from the fifteen analysts that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $26.8462.

Several equities analysts have recently commented on ACHC shares. UBS Group boosted their price objective on Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a research report on Friday, April 17th. Cantor Fitzgerald increased their target price on Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a research report on Friday, May 1st. Barclays boosted their price target on Acadia Healthcare from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Thursday, April 30th. Guggenheim upped their price target on Acadia Healthcare from $26.00 to $31.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Finally, Royal Bank Of Canada increased their price objective on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a report on Monday, May 4th.

Hedge Funds Weigh In On Acadia Healthcare

Several institutional investors have recently bought and sold shares of ACHC. EverSource Wealth Advisors LLC increased its holdings in Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after acquiring an additional 497 shares during the last quarter. Wells Fargo & Company MN boosted its holdings in shares of Acadia Healthcare by 208.9% during the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after purchasing an additional 1,510 shares during the last quarter. Bayforest Capital Ltd bought a new position in shares of Acadia Healthcare during the 4th quarter valued at about $52,000. GAMMA Investing LLC grew its position in shares of Acadia Healthcare by 124.7% during the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock valued at $69,000 after purchasing an additional 2,698 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd increased its holdings in shares of Acadia Healthcare by 4,264.8% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after purchasing an additional 5,203 shares during the last quarter.

Acadia Healthcare Price Performance

Shares of ACHC stock opened at $31.91 on Tuesday. The company has a market capitalization of $2.93 billion, a price-to-earnings ratio of -2.61, a PEG ratio of 10.64 and a beta of 0.64. Acadia Healthcare has a one year low of $11.43 and a one year high of $32.82. The company’s fifty day moving average price is $25.70 and its 200-day moving average price is $21.24. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company had revenue of $828.80 million during the quarter, compared to the consensus estimate of $823.51 million. During the same quarter in the prior year, the firm posted $0.40 EPS. Acadia Healthcare’s quarterly revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Sell-side analysts expect that Acadia Healthcare will post 1.5 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.